Other programs

AntibioTx has identified, patent protected and microbiologically validated a number of follow-on programs that are currently in the discovery or early pre-clinical stages of development. AntibioTx has also engaged in external collaborations to utilize the unique properties of the Tx-class and turn the class into the beta-lactams of the 21st century.

The Tx-class has potential to make a significant and lasting impact on the fight against antibiotic resistance due to a number of factors:

  • Novel mechanism of action with selective and broad coverage of challenging pathogens
  • Effectively overcomes current multi-drug resistant bacteria
  • >10.000-fold better than marketed antibiotics in delaying the onset of de novo resistance
  • Chemical scaffold provide opportunities to develop new compositions of matter and target a variety of infections
  • Compound class is risk-reduced and has shorter time to market due to proven human safety


For more information, please contact AntibioTx at info@antibiotx.com